BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 163165)

  • 1. Plasma adenosine 3':5'-cyclic monophosphate response to glucagon in thyroid disease.
    Elkeles RS; Lazarus JH; Siddle K; Campbell AK
    Clin Sci Mol Med; 1975 Jan; 48(1):27-31. PubMed ID: 163165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cyclic AMP response to glucagon as an index of tissue responsiveness to thyroid hormone.
    Paisey R; Elkeles RS; Hambley J; Belchetz PE
    Diabete Metab; 1978 Dec; 4(4):267-70. PubMed ID: 215472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid function and plasma cyclic AMP response to intravenous glucagon.
    Madsen SN
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):760-8. PubMed ID: 196468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the usefulness of the plasma adenosine 3' 5' - cyclic monophosphate response to glucagon in thyroid disease.
    Mac Neil S; Hendy GN; Amirrasooli H; Daggett PR; Tomlinson S
    J Endocrinol Invest; 1980; 3(4):401-4. PubMed ID: 6259251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of thyroid function on the increase of plasma cyclic AMP following glucagon injection (author's transl)].
    Jäckel W; Heimes J; Herrmann J
    J Clin Chem Clin Biochem; 1980 Dec; 18(12):909-15. PubMed ID: 6259272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of plasma leptin concentrations in obese hyperinsulinaemic hypothyroidism before and after treatment.
    Kautzky-Willer A; Ludwig C; Nowotny P; Roden A; Huemer C; Widhalm K; Vierhapper H; Waldhäusl W; Roden M
    Eur J Clin Invest; 1999 May; 29(5):395-403. PubMed ID: 10354196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of propranolol on the plasma cyclic AMP and cyclic GMP levels to massive doses of glucagon in euthyroid and hyperthyroid subjects.
    Földes J; Gyertyánfy G; Piroska E; Juhász J
    Acta Med Acad Sci Hung; 1977; 34(4):227-34. PubMed ID: 218419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Plasma cyclic AMP response to glucagon in thyroid disease.
    Elkeles RS; Siddle K; Lazarus JH; Campbell AK; Addison GM
    Clin Sci Mol Med; 1974 Sep; 47(3):14P-15P. PubMed ID: 4370892
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucose tolerance and insulin and C-peptide responses after various insulin secretory stimuli in hyper- and hypothyroid subjects before and after treatment.
    Ahrén B; Lundquist I; Hedner P; Valdemarsson S; Scherstén B
    Diabetes Res; 1985 Mar; 2(2):95-103. PubMed ID: 2412749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of somatostatin on plasma cyclic AMP and metabolic substrate responses to i.v. adrenaline and glucagon in humans.
    Nistrup Madsen S; Christensen SE; Hansen AP; Thode J
    Clin Endocrinol (Oxf); 1981 Nov; 15(5):431-7. PubMed ID: 6120054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired responsiveness to the effect of glucagon on plasma adenosine 3':5'-cyclic monophosphate in normal man.
    Hendy GN; Tomlinson S; O'Riordan JL
    Eur J Clin Invest; 1977 Jun; 7(3):155-60. PubMed ID: 196859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cyclic nucleotide responses to insulin-induced hypoglycaemia and methacholine in patients with hyperthyroidism.
    Okada F; Ide H; Hata S; Honma M; Ui M
    Eur J Clin Invest; 1980 Feb; 10(1):81-6. PubMed ID: 6245892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cyclic nucleotide levels in hyperthyroidism.
    Lin T
    Acta Endocrinol (Copenh); 1979 Jan; 90(1):62-8. PubMed ID: 216209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of ketonemia in fasting patients with hyperthyroidism.
    Bartels PD; Kristensen LO; Heding LG; Sestoft L
    Acta Med Scand Suppl; 1979; 624():43-7. PubMed ID: 284713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in plasma glucose, insulin (IRI), glucagon (IRG) and free fatty acids (FFA) following alanine loading in hyperthyroid patients.
    Ida H; Yamamoto T; Ninomiya H; Sasaki H; Asano T; Okumura M
    Endocrinol Jpn; 1987 Dec; 34(6):937-45. PubMed ID: 3330025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses of plasma adenosine 3',5'-monophosphate, blood glucose and plasma insulin to glucagon in humans.
    Søvik O; Heiervang E; Aksnes L; Selvig S
    Scand J Clin Lab Invest; 1981 Nov; 41(7):669-74. PubMed ID: 6280266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma adenosine 3':5'--cyclic monophosphate response to glucagon in uremia.
    Vlachoyannis J; Schoeppe W
    Klin Wochenschr; 1982 Jul; 60(13):651-7. PubMed ID: 6289001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma somatostatin is elevated in primary hypothyroidism compared with hyperthyroidism.
    Skare S; Hanssen KF; Norman N
    Acta Endocrinol (Copenh); 1986 Mar; 111(3):331-5. PubMed ID: 2870598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between thyroid function and the renal response to parathyroid hormone.
    Ashby JP; MacPherson JN; Strong JA
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):167-70. PubMed ID: 196793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP infusion and blood sugar, serum insulin and serum nonesterified fatty acid responses to glucose in recent experimental hyperthyroid dogs.
    Renauld A; Garrido D
    Acta Physiol Pharmacol Ther Latinoam; 1992; 42(4):255-76. PubMed ID: 1343982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.